HACKENSACK UMC AT PASCACK VALLEY
1. Target Overview & Investment Thesis
HACKENSACK UMC AT PASCACK VALLEY is a 78-bed suburban community hospital in BERGEN, NJ with $148.8M in net patient revenue and a 15.0% operating margin. The hospital serves a payer mix of 32.1% Medicare, 0.5% Medicaid, and 67.3% commercial.
Thesis: Turnaround. Our ML models identify $11.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.0% to 22.3% (+736bps).
| Net Revenue HCRIS | $148.8M |
| Current EBITDA COMPUTED | $22.3M |
| Operating Margin COMPUTED | 15.0% |
| Occupancy HCRIS | 55.6% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 26.4% |
| Distress Probability ML | 44.6% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of 15.0% places it above the state median. Among 38 size-comparable peers (39-156 beds), the median margin is -6.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (39-156), prioritizing same-state peers. 38 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HACKENSACK UMC AT PASCACK VALL (Target) | NJ | 78 | $148.8M | 15.0% |
| SOUTHERN OCEAN MEDICAL CENTER | NJ | 147 | $233.0M | 10.5% |
| DEBORAH HEART AND LUNG CENTER | NJ | 85 | $211.9M | -5.5% |
| ST LUKES WARREN HOSPITAL | NJ | 92 | $200.8M | 28.1% |
| ST. MICHAELS MEDICAL CENTER | NJ | 147 | $198.6M | -13.6% |
| ROBERT WOOD JOHNSON HOSPITAL @ | NJ | 152 | $193.9M | -15.5% |
| NEWTON MEDICAL CENTER | NJ | 139 | $189.3M | -6.7% |
| BERGEN NEW BRIDGE MEDICAL CENT | NJ | 101 | $187.0M | -39.4% |
| ST. MARYS HOSPITAL - PASSAIC | NJ | 122 | $173.8M | 0.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $95K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $22.3M |
| + RCM Uplift | +$11.0M |
| Pro Forma EBITDA | $33.2M |
| Current Margin | 15.0% |
| Pro Forma Margin | 22.3% |
| WC Released (1x) | $5.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $34.2M | $256.3M | 7.49x | 49.6% |
| Base (11x exit) | 10.0x | 11.0x | $34.2M | $293.1M | 8.56x | 53.6% |
| Bull Case | 9.0x | 11.0x | $30.8M | $340.3M | 11.04x | 61.7% |
| Bull (12x exit) | 9.0x | 12.0x | $30.8M | $380.4M | 12.34x | 65.3% |
| Bear Case | 11.0x | 10.0x | $37.7M | $190.4M | 5.06x | 38.3% |
| Bear (11x exit) | 11.0x | 11.0x | $37.7M | $221.7M | 5.89x | 42.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 38 hospitals with 39-156 beds
- Same-state prioritization (n=39)
- Comp margins: P25=-25.8% / P50=-6.3% / P75=2.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.